PD-L1 Expression and its Association with Clinicopathological Characteristics of Non-Small Cell Lung Carcinoma: A Cross-sectional Study

Introduction: Lung cancer remains the leading cause of cancerrelated mortality worldwide with Non-Small Cell Lung Carcinoma (NSCLC) constituting the majority of cases. Programmed Death Ligand 1 (PD-L1) expression on tumour cells has emerged as a crucial biomarker guiding immunotherapy. However, the relationship between PD-L1 expression and clinicopathological characteristics in NSCLC remains unclear. Aim: To evaluate the distribution of PD-L1 expression in non-small cell lung cancer (NSCLC) and its association with histopathological subtypes. Materials and Methods: The cross-sectional study was conducted over a period of 17 months, from May 2023 to October 2024, in the Department of Pathology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. A cross-sectional study of 40 NSCLC cases assessed PD-L1 expression by Immunohistochemistry (IHC), classified as negative (<1%), weakly positive (1-50%) or strongly positive (>50%). Associations with age, gender, smoking history, and histological subtype were analysed. The results were analysed using SPSS version 23.0 software. The quantitive data were presented as mean and standard deviation, whereas qualitative data were represented as frequencies and percentages. Chi-square test was used to determine the association between of expression with parameters such as age, gender, histopathological subtypes. Results: Among the 40 NSCLC cases, males accounted for the majority (72.5%). PD-L1 expression was negative in 18 cases (45%), weakly positive in 15 (37.5%) and strongly positive in 7 (17.5%). Although PD-L1 positivity was proportionally higher among females and non-smokers than among males and smokers, respectively, the associations with gender (p=0.0812) and smoking status (p=0.0522) were not statistically significant. SCC demonstrated a higher proportion of strong PD-L1 expression (12.5%) compared with adenocarcinoma (5%); however, this difference was also not statistically significant. No significant association was observed between PD-L1 expression and age. Conclusion: PD-L1 expression in NSCLC varies across demographic and histological factors, with trends suggesting higher expression among females and non-smokers. Larger, multi-center studies are warranted to clarify these associations and support personalised immunotherapy approaches in diverse populations.

Authors

Publication Details

Journal
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Published
2026-11-18
DOI
https://doi.org/10.7860/jcdr/2026/89658.24817
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PD-L1 Expression and its Association with Clinicopathological Characteristics of Non-Small Cell Lung Carcinoma: A Cross-sectional Study

Siddiq Mukkamil Ahmed, Dayanand Siddappa Biligi, ujata Balasaheb Metan, Krishnapriya Raja
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Cancer Immunotherapy and Biomarkers
article

PD-L1 Expression and its Association with Clinicopathological Characteristics of Non-Small Cell Lung Carcinoma: A Cross-sectional Study

Siddiq Mukkamil Ahmed, Dayanand Siddappa Biligi, ujata Balasaheb Metan, Krishnapriya Raja
article en

Abstract

Introduction: Lung cancer remains the leading cause of cancerrelated mortality worldwide with Non-Small Cell Lung Carcinoma (NSCLC) constituting the majority of cases. Programmed Death Ligand 1 (PD-L1) expression on tumour cells has emerged as a crucial biomarker guiding immunotherapy. However, the relationship between PD-L1 expression and clinicopathological characteristics in NSCLC remains unclear. Aim: To evaluate the distribution of PD-L1 expression in non-small cell lung cancer (NSCLC) and its association with histopathological subtypes. Materials and Methods: The cross-sectional study was conducted over a period of 17 months, from May 2023 to October 2024, in the Department of Pathology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. A cross-sectional study of 40 NSCLC cases assessed PD-L1 expression by Immunohistochemistry (IHC), classified as negative (<1%), weakly positive (1-50%) or strongly positive (>50%). Associations with age, gender, smoking history, and histological subtype were analysed. The results were analysed using SPSS version 23.0 software. The quantitive data were presented as mean and standard deviation, whereas qualitative data were represented as frequencies and percentages. Chi-square test was used to determine the association between of expression with parameters such as age, gender, histopathological subtypes. Results: Among the 40 NSCLC cases, males accounted for the majority (72.5%). PD-L1 expression was negative in 18 cases (45%), weakly positive in 15 (37.5%) and strongly positive in 7 (17.5%). Although PD-L1 positivity was proportionally higher among females and non-smokers than among males and smokers, respectively, the associations with gender (p=0.0812) and smoking status (p=0.0522) were not statistically significant. SCC demonstrated a higher proportion of strong PD-L1 expression (12.5%) compared with adenocarcinoma (5%); however, this difference was also not statistically significant. No significant association was observed between PD-L1 expression and age. Conclusion: PD-L1 expression in NSCLC varies across demographic and histological factors, with trends suggesting higher expression among females and non-smokers. Larger, multi-center studies are warranted to clarify these associations and support personalised immunotherapy approaches in diverse populations.

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon